Pubblicazioni ufficiali BioSenic SA

Azioni

Mercato chiuso - Euronext Bruxelles Altri mercati azionari 17:36:25 30/04/2024			Variaz. 5gg	Var. 1 gen.
0,0148 ^EUR	-5,13%		-28,16%	-75,82%

12/03	Biosenic S.A. rilascia i dettagli dell'approccio di somministrazione ottimizzato in vista della sperimentazione di Fase 3 di OATO per la malattia cronica del trapianto e dell'ospite (Graft-Versus-Host Disease)	CI
30/01	L'unità BioSenic ottiene un brevetto canadese per la piattaforma terapeutica	MT

Monthly statement on voting rights	29/03	CO
Monthly statement on voting rights	29/03	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	29/02	CO
Changes in management and corporate officers	10/01	CO
Changes in management and corporate officers	10/01	CO
Business information	08/01	CO
Business information	08/01	CO
3rd quarter turnover	25/10/23	CO
3rd quarter turnover	25/10/23	CO
Threshold crossings	17/10/23	CO
Threshold crossings	17/10/23	CO
Monthly statement on voting rights	30/09/23	CO
Monthly statement on voting rights	30/09/23	CO
1st-half-year results	07/09/23	CO
Half-year report	07/09/23	CO
Monthly statement on voting rights	31/08/23	CO
Monthly statement on voting rights	31/08/23	CO
Monthly statement on voting rights	03/07/23	CO
Monthly statement on voting rights	03/07/23	CO
Monthly statement on voting rights	31/05/23	CO
1st quarter turnover	22/05/23	CO
1st quarter turnover	22/05/23	CO
Ordinary general shareholder meeting	15/05/23	CO
Ordinary general shareholder meeting	15/05/23	CO